Every drug prescribed to your policyholders…
…brings the potential for costly ADRs.
Costly to your policyholders’ health
and with massive cost liabilities for your business
Globally, preventable medication errors cost over $1 trillion each year and represent 15-20% of national health budgets.
A 2006 report published by the Board of Science of the British Medical Association (BMA) estimates that 250,000 people a year are admitted to hospital suffering harmful effects after taking drugs mainly prescribed by doctors in primary care, with a cost to the NHS of about £466 million a year.
What are the costs to health insurance companies if we extrapolate those rates into the population of health insurance policyholders for ADR associated hospital admissions, medications or even litigations?
Click here to contact us now by email or schedule a call
Turning the tide on ADRs
The power of QS AI
Quantum Satis is a powerful AI-based medical evaluation tool which supports decision-making at doctor/patient consultations. It reveals potential ADRs, drug specific indicators (such as inappropriate drugs, drug duplication etc) and diagnosis specific indicators (drug-disease interactions, contraindications etc).
It interrogates the relevant drug combination data from across the multiple datasets available to the healthcare organisation. These can include individual patient history, physiology and symptoms resulting in a powerful analysis of the potential conflicts relating to that individual.
Preventative action on ADRs
Where Quantum Satis is used systematically across every consultation involving your policyholders, the incremental reduction of risk of hidden or unexpected drug conflicts across the group will amount to a significant reduction in real world costs.
The value-adding benefit of the QS System®
Analysis shows claims can be significantly reduced where QS reviews are undertaken at every consultation.
Please contact me
The massive Adverse Drug Reaction problem encountered globally by healthcare organisations
Annual rise in hospital admissions due to ADRs
Globally, preventable medication errors cost over $1 trillion each year, of which the U.S. economy alone incurs $21 billion.
Adverse Drug Reactions (ADRs) are among the leading causes of additional complications and longer hospital stays, morbidity and mortality.
It has been estimated that ADRs are the 4th largest cause for mortality in the USA, resulting in the deaths of several thousands of patients each year. National USA Vital Statistics System data showed that from 1999 to 2006, the rate of ADR-related deaths increased from 0.08 to 0.12 per 100,000 persons.
It is estimated that up to 70% of ADRs leading to emergency department visits are preventable, with some countries spending up to 15-20% of their healthcare budgets treating otherwise avoidable ADRs.
The strain that ADRs place on the health care system is significant yet preventable.